Frank Litvack

Frank Litvack is the founder of Progressive Angioplasty Systems, Inc. (1989) where the title held is Chairman & Chief Executive Officer; iTherX Pharmaceuticals, Inc. (1992) with the title Director; Fasturn, Inc. (1999) as Chairman & Chief Executive Officer; Savacor, Inc. (2000) as Chairman & Chief Executive Officer; Conor Medsystems LLC (2002) as Chairman & Chief Executive Officer; Pura Vida Investments LLC (2012) as Member; TrialTech Medical, Inc. (2018) as Chairman; VIDA FLaSH Acquisitions (2021) as Chief Executive Officer & Director.
Dr. Litvack is also the founder of Advanced Interventional Systems, Inc.,Credence MedSystems, Inc.,Levation Pharma Ltd...
Dr. Litvack is currently Executive Chairman at Capricor, Inc. and Capricor Therapeutics, Inc. since 2013.
Dr. Litvack is Chairman at V-Wave Ltd. Dr. Litvack is Director at Cardiovascular Research Foundation and Tanenbaum Open Science Institute.
Dr. Litvack is Professor at the University of California, Los Angeles.
Dr. Litvack was Member at the University of California, Davis; Calmedica LLC since 1985; Pura Vida Investments LLC (Private Equity); and Wilhareka Partners LLC since 2023.
Former positions include Director at One Lambda, Inc., ReCor Medical, Inc., CathWorks Ltd., MedAvail, Inc., and MedAvail Holdings, Inc. Dr. Litvack was Co-Director at Cardiovascular Intervention Center.
Dr. Litvack was Principal at Cedars-Sinai Medical Center from 1989 to 1997.
Education includes undergraduate and doctorate degrees from McGill University.